Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06088355 · ClinicalTrials.gov registry record · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
A NA study of Parkinson Disease and Movement Disorders, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 123
- Enrollment target
- 1
- Study location
NCT06088355: Recruiting NA study of Parkinson Disease and Movement Disorders, sponsored by VA Office of Research and Development.
NCT06088355 is a NA study of Parkinson Disease and Movement Disorders that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 123 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06088355, a NA study of Parkinson Disease and Movement Disorders, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
- 1
- Study location
Study Summary
Veterans with mid to later stage Parkinson's disease (PD) may not be able to work out as hard as they need to, to prevent brain cell loss. Maybe they could work out longer and more frequently to make up for this during their good times and good weeks and then rest during the bad weeks. The investigators will compare how effective working out a lot one week per month with a break of three weeks is to continuously exercising weekly with no breaks in people with mid stage PD. The investigators will look at how fast participants walk per minute, whether they become more physically active, the biochemicals in their blood, and at how stiff their blood vessels are before and after the exercise.
Primary Outcome
Gait Cadence is the number of human steps taken per minute while walking.
Conditions Studied
Interventions
- BEHAVIORAL HV-PDAE: High Volume Partnered Dance Aerobic Exercise
- BEHAVIORAL MV-PDAE: Moderate Volume Partnered Dance Aerobic Exercise
- BEHAVIORAL MV-WALK: Moderate Volume Walking
Study Locations (1)
Georgia
- Atlanta VA Medical and Rehab Center, Decatur, GA - Decatur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2025-01-25 |
| Est. Completion | 2029-06-02 |
| Phase | NA |
What NCT06088355 shows while recruiting
NCT06088355 is an interventional study that assigns participants to a tested intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 3 interventions - of which HV-PDAE: High Volume Partnered Dance Aerobic Exercise is the first listed.
NCT06088355 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06088355 about?
NCT06088355 is a clinical study titled "Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease". Veterans with mid to later stage Parkinson's disease (PD) may not be able to work out as hard as they need to, to prevent brain cell loss. Maybe they could work out longer and more frequently to make up for this during their good times and good weeks and then rest during the bad weeks. The investiga...
What is the current status of trial NCT06088355?
This trial is currently recruiting. It is a NA study. The enrollment target is 123 participants. The study started on 2025-01-25. Estimated completion is 2029-06-02.
What conditions does trial NCT06088355 study?
This clinical trial studies the following conditions: Parkinson Disease, Movement Disorders, Neurodegeneration.
What interventions are being tested in trial NCT06088355?
The interventions under investigation include: HV-PDAE: High Volume Partnered Dance Aerobic Exercise (BEHAVIORAL), MV-PDAE: Moderate Volume Partnered Dance Aerobic Exercise (BEHAVIORAL), MV-WALK: Moderate Volume Walking (BEHAVIORAL).
Who is sponsoring clinical trial NCT06088355?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06088355 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06088355's enrollment target sits among peer trials
123 69th of 297 higher than 229 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
- NCT06362252 · 123 participants · Phase 1
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI